BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

NCT00326963 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Background ARVs
DRUG: PI
DRUG: enfuvirtide [Fuzeon]

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]